Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

A study of the capability of manufacturers of generic hormonal contraceptives in lower- and middle-income countries.

Hall PE, Oehler J, Woo P, Zardo H, Chinery L, Singh JS, Jooseery SH, Essah NM.

Contraception. 2007 Apr;75(4):311-7. Epub 2007 Jan 16.

PMID:
17362712
2.

Active pharmaceutical ingredients for antiretroviral treatment in low- and middle-income countries: a survey.

Fortunak JM, de Souza RO, Kulkarni AA, King CL, Ellison T, Miranda LS.

Antivir Ther. 2014;19 Suppl 3:15-29. doi: 10.3851/IMP2897. Epub 2014 Oct 13.

3.

Compendial issues: WHO.

Kopp-Kubel S.

J Parenter Sci Technol. 1992 Nov-Dec;46(6):201-5.

PMID:
1474431
4.

WHO expert committee on specifications for pharmaceutical preparations. Fortieth report.

WHO Expert Committee on Specifications for Pharmaceutical Preparations.

World Health Organ Tech Rep Ser. 2006;937:1-461, back cover.

PMID:
16836287
5.

Influence of manufacturing practices on quality of pharmaceutical products manufactured in Kenya.

Orwa JA, Keter LK, Ouko SP, Kibwage IO, Rukunga GM.

East Afr Med J. 2004 Jun;81(6):287-92.

PMID:
16167675
7.
8.

WHO Expert Committee on Specifications for Pharmaceutical Preparations.

World Health Organization.

World Health Organ Tech Rep Ser. 2005;929:1-142, backcover.

PMID:
16353684
10.

WHO Expert Committee on Specifications for Pharmaceutical Preparations.

[No authors listed]

World Health Organ Tech Rep Ser. 2003;917:i-viii, 1-125, back cover.

PMID:
15024913
11.

Injectable contraceptive synthesis: an example of international cooperation.

Crabbè P, Diczfalusy E, Djerassi C.

Science. 1980 Aug 29;209(4460):992-4.

PMID:
7403868
13.
16.

Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.

Morin-Papunen L, Martikainen H, McCarthy MI, Franks S, Sovio U, Hartikainen AL, Ruokonen A, Leinonen M, Laitinen J, Järvelin MR, Pouta A.

Am J Obstet Gynecol. 2008 Nov;199(5):529.e1-529.e10. doi: 10.1016/j.ajog.2008.04.013. Epub 2008 Jun 4.

PMID:
18533124
17.

Drugs for developing countries. Uncharitable stance from Oxfam.

Wenz C.

Nature. 1982 Dec 2;300(5891):395.

PMID:
7144894
18.

WHO informal consultation on regulatory evaluation of therapeutic biological medicinal products held at WHO Headquarters, Geneva, 19-20 April 2007.

Joung J, Robertson JS, Griffiths E, Knezevic I; WHO Informal Consultation Group.

Biologicals. 2008 Jul;36(4):269-76. doi: 10.1016/j.biologicals.2007.11.004. Epub 2008 Jan 22.

PMID:
18218324
19.
20.

Ensuring supplies of quality diethylcarbamazine citrate (DEC).

Kitler ME, Zagaria N.

J Clin Pharmacol. 2003 May;43(5):477-90.

PMID:
12751269

Supplemental Content

Support Center